File Download
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Neratinib in the extended adjuvant treatment of patients from Asia with early-stage HER2+ breast cancer after trastuzumab-based therapy: exploratory analyses from the phase III ExteNET trial
Title | Neratinib in the extended adjuvant treatment of patients from Asia with early-stage HER2+ breast cancer after trastuzumab-based therapy: exploratory analyses from the phase III ExteNET trial |
---|---|
Authors | |
Issue Date | 2017 |
Citation | San Antonio Breast Cancer Congress (SABCS) 40th Annual Meeting, San Antonio, TX, 5-9 December 2017 How to Cite? |
Persistent Identifier | http://hdl.handle.net/10722/249353 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Iwata, H | - |
dc.contributor.author | Masuda, N | - |
dc.contributor.author | Kim, S-B | - |
dc.contributor.author | Inoue, K | - |
dc.contributor.author | Rai, TY | - |
dc.contributor.author | Fujita, TCC | - |
dc.contributor.author | Shen, Z-Z | - |
dc.contributor.author | Chiu, WYJ | - |
dc.contributor.author | Ohtani, S | - |
dc.contributor.author | Takahashi, M | - |
dc.contributor.author | Yamamoto, N | - |
dc.contributor.author | Miyaki, T | - |
dc.contributor.author | Sun, Q | - |
dc.contributor.author | Lu, YS | - |
dc.contributor.author | Xu, B | - |
dc.contributor.author | Yap, YS | - |
dc.contributor.author | Bustam, A | - |
dc.contributor.author | Yee, Y | - |
dc.contributor.author | Zhang, B | - |
dc.contributor.author | Bryce, R | - |
dc.contributor.author | Chan, A | - |
dc.date.accessioned | 2017-11-21T03:00:58Z | - |
dc.date.available | 2017-11-21T03:00:58Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | San Antonio Breast Cancer Congress (SABCS) 40th Annual Meeting, San Antonio, TX, 5-9 December 2017 | - |
dc.identifier.uri | http://hdl.handle.net/10722/249353 | - |
dc.language | eng | - |
dc.relation.ispartof | San Antonio Breast Cancer Congress (SABCS) | - |
dc.title | Neratinib in the extended adjuvant treatment of patients from Asia with early-stage HER2+ breast cancer after trastuzumab-based therapy: exploratory analyses from the phase III ExteNET trial | - |
dc.type | Conference_Paper | - |
dc.identifier.email | Chiu, WYJ: jwychiu@hku.hk | - |
dc.identifier.authority | Chiu, WYJ=rp01917 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.hkuros | 283146 | - |
dc.publisher.place | San Antonio, TX | - |